A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2016-09-27
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to investigate the pharmacokinetic
(the exposure of the trial drug in the body) properties of insulin degludec/insulin aspart in
healthy Chinese subjects.